Patent details

EP1885339 Title: FORMULATIONS OF A SRC/ABL INHIBITOR

Basic Information

Publication number:
EP1885339
PCT Application Number:
PCT/US/2006/017073
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP067699975
PCT Publication Number:
WO/2006/121742
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMULATIONS OF A SRC/ABL INHIBITOR
French Title of Invention:
FORMULATIONS D'INHIBITEUR DE SRC/ABL
German Title of Invention:
FORMULIERUNGEN EINES SRC-/ABL-HEMMERS
SPC Number:

Dates

Filing date:
04/05/2006
Grant date:
29/07/2015
EP Publication Date:
29/07/2015
PCT Publication Date:
16/11/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/02/2008
EP B1 Publication Date:
29/07/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
04/05/2026
Renunciation date:
Revocation date:
10/05/2021
Annulment date:

Owner

From:
23/01/2019
 
 

Name:
Bristol-Myers Squibb Holdings Ireland Unlimited Company
Address:
Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

History of Owners

From:
04/05/2006
To:
23/01/2019

Name:
Bristol-Myers Squibb Holdings Ireland
Address:
Hinterbergstrasse 16, 6312 Steinhausen, Switzerland (CH)

Agent

Name:
MARKS & CLERK LLP
From:
03/09/2015
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
MOTHERAM Rajeshwar
Address:
United States (US)

2

Name:
GAO Julia ZH
Address:
United States (US)

Priority

Priority Number:
678030 P
Priority Date:
05/05/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/16;

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
VRV
Bulletin edition number:
2021/08
Publication date:
01/07/2021
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:
202127
Publication date:
07/07/2021
Description:
Revocation of the European patent

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20190000045A
Date Registered:
23/01/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Bristol-Myers Squibb Holdings Ireland Unlimited Company
Address:
Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/04/2021
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
23/01/2019 Outgoing Correspondence 1
23/01/2019 Request For Change 6
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56